News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
762,970 Results
Type
Article (47432)
Company Profile (346)
Press Release (715174)
Multimedia
Podcasts (129)
Webinars (25)
Section
Business (213757)
Career Advice (2230)
Deals (36745)
Drug Delivery (136)
Drug Development (83634)
Employer Resources (181)
FDA (17212)
Job Trends (15598)
News (360433)
Policy (34149)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2803)
Accelerated approval (42)
Adcomms (28)
Allergies (166)
Alliances (52939)
ALS (197)
Alzheimer's disease (1811)
Antibody-drug conjugate (ADC) (387)
Approvals (17501)
Artificial intelligence (655)
Autoimmune disease (233)
Automation (52)
Bankruptcy (370)
Best Places to Work (12076)
BIOSECURE Act (20)
Biosimilars (204)
Biotechnology (229)
Bladder cancer (180)
Brain cancer (65)
Breast cancer (709)
Cancer (5469)
Cardiovascular disease (464)
Career advice (1895)
Career pathing (40)
CAR-T (315)
CDC (64)
Celiac Disease (2)
Cell therapy (842)
Cervical cancer (42)
Clinical research (71781)
Collaboration (2007)
Company closure (6)
Compensation (1287)
Complete response letters (77)
COVID-19 (2865)
CRISPR (109)
C-suite (1019)
Cystic fibrosis (155)
Data (7174)
Decentralized trials (3)
Denatured (49)
Depression (160)
Dermatology (59)
Diabetes (568)
Diagnostics (7179)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (317)
Drug pricing (204)
Drug shortages (32)
Duchenne muscular dystrophy (278)
Earnings (93115)
Editorial (63)
Employer branding (22)
Employer resources (159)
Events (124292)
Executive appointments (1082)
FDA (20717)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1692)
Gene editing (230)
Generative AI (59)
Gene therapy (697)
GLP-1 (1065)
Government (4953)
Grass and pollen (7)
Guidances (399)
Healthcare (19942)
HIV (77)
Huntington's disease (52)
IgA nephropathy (94)
Immunology and inflammation (285)
Immuno-oncology (85)
Indications (158)
Infectious disease (3194)
Inflammatory bowel disease (210)
Inflation Reduction Act (14)
Influenza (133)
Intellectual property (282)
Interviews (356)
IPO (17066)
IRA (52)
Job creations (3857)
Job search strategy (1578)
JPM (64)
Kidney cancer (19)
Labor market (94)
Layoffs (584)
Leadership (39)
Legal (8307)
Liver cancer (101)
Longevity (29)
Lung cancer (729)
Lymphoma (411)
Machine learning (54)
Management (63)
Manufacturing (955)
MASH (182)
Medical device (14695)
Medtech (14776)
Mergers & acquisitions (20851)
Metabolic disorders (1451)
mRNA (200)
Multiple sclerosis (174)
NASH (20)
Neurodegenerative disease (402)
Neuropsychiatric disorders (100)
Neuroscience (3250)
Neurotech (1)
NextGen: Class of 2026 (6968)
Non-profit (4823)
Now hiring (73)
Obesity (677)
Opinion (311)
Ovarian cancer (187)
Pain (236)
Pancreatic cancer (263)
Parkinson's disease (348)
Partnered (35)
Patents (570)
Patient recruitment (611)
Peanut (63)
People (62039)
Pharmaceutical (70)
Pharmacy benefit managers (33)
Phase 1 (22472)
Phase 2 (31554)
Phase 3 (23497)
Pipeline (7239)
Policy (330)
Postmarket research (2632)
Preclinical (9617)
Press Release (72)
Prostate cancer (284)
Psychedelics (51)
Radiopharmaceuticals (323)
Rare diseases (1035)
Real estate (6321)
Recruiting (72)
Regulatory (25949)
Reports (56)
Research institute (2611)
Resumes & cover letters (374)
Rett syndrome (32)
RNA editing (20)
RSV (88)
Schizophrenia (169)
Series A (282)
Series B (205)
Service/supplier (15)
Sickle cell disease (110)
Special edition (22)
Spinal muscular atrophy (170)
Sponsored (47)
Startups (3915)
State (2)
Stomach cancer (18)
Supply chain (121)
Tariffs (86)
The Weekly (77)
Vaccines (1130)
Venture capital (105)
Weight loss (440)
Women's health (113)
Worklife (21)
Date
Today (13)
Last 7 days (658)
Last 30 days (2721)
Last 365 days (31013)
2026 (8273)
2025 (31300)
2024 (36491)
2023 (41424)
2022 (52725)
2021 (57325)
2020 (56115)
2019 (49011)
2018 (36938)
2017 (33831)
2016 (33503)
2015 (39678)
2014 (33225)
2013 (28313)
2012 (30581)
2011 (31100)
2010 (29193)
Location
Africa (807)
Alabama (93)
Alaska (7)
Arizona (350)
Arkansas (15)
Asia (42501)
Australia (7122)
California (12521)
Canada (3557)
China (1271)
Colorado (536)
Connecticut (544)
Delaware (378)
Europe (94169)
Florida (1865)
Georgia (414)
Hawaii (3)
Idaho (67)
Illinois (1005)
India (82)
Indiana (571)
Iowa (23)
Japan (497)
Kansas (136)
Kentucky (49)
Louisiana (41)
Maine (73)
Maryland (1519)
Massachusetts (9066)
Michigan (374)
Minnesota (702)
Mississippi (7)
Missouri (150)
Montana (37)
Nebraska (29)
Nevada (140)
New Hampshire (89)
New Jersey (3343)
New Mexico (33)
New York (3305)
North Carolina (1621)
North Dakota (10)
Northern California (6154)
Ohio (386)
Oklahoma (24)
Oregon (44)
Pennsylvania (2529)
Puerto Rico (27)
Rhode Island (51)
South America (1196)
South Carolina (78)
South Dakota (1)
Southern California (4930)
Tennessee (204)
Texas (1998)
United States (44693)
Utah (380)
Vermont (1)
Virginia (302)
Washington D.C. (83)
Washington State (1017)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
762,970 Results for "critical outcome technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
December 17, 2025
·
5 min read
Press Releases
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
January 15, 2026
·
6 min read
Press Releases
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
March 19, 2026
·
4 min read
Press Releases
Hubly Surgical awarded Breakthrough Technology Designation for Neurosurgical Products with Premier, Inc.
March 3, 2026
·
2 min read
Press Releases
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
March 12, 2026
·
5 min read
Press Releases
Imperative Care Initiates CLEAR-IT Clinical Study to Address Critical Gaps in Clinical Standards for Peripheral Thromboembolism
March 26, 2026
·
6 min read
Press Releases
DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.
February 3, 2026
·
2 min read
Press Releases
InnoCare Announces Key Developments of Critical Clinical Studies
February 26, 2026
·
3 min read
Press Releases
Quanta System Inc.: Strengthening the U.S. Presence of Italian Laser Technology
March 1, 2026
·
4 min read
Press Releases
Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting
New interim results from the EpiCom trial, a prospective evaluation of behavioral outcomes in patients with tuberous sclerosis complex, suggest improvements in non-seizure outcomes Eight abstracts, including four late-breaking abstracts, underscore Jazz’s continued commitment to the epilepsy community and advancing the comprehensive treatment for rare forms of epilepsy
December 5, 2025
·
12 min read
1 of 76,297
Next
